Clinical Trial Update: Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of dapagliflozin alone and with saxagliptin plus metformin versus sulphonylurea in type 2 diabetes with inadequate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, Inadequate Glycaemic Control | Phase 4 | Status: COMPLETED | Results posted: 2019-03-26